Prosthesis-patient mismatch: An update

Current Cardiology Reports

Volumn 13, Issue 3, 2011, Pages 250-257

  Dumesnil, Jean G ^a   Pibarot, Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic stenosis; Doppler echocardiography; Heart valve disease; Heart valve prosthesis; Hemodynamics

Indexed keywords

AORTA VALVE REPLACEMENT; BODY SIZE; BODY SURFACE; CORONARY FLOW RESERVE; DISEASE ASSOCIATION; EXERCISE; GRAFT SURVIVAL; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; MITRAL VALVE REPLACEMENT; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROSTHESIS FAILURE; PROSTHESIS PATIENT MISMATCH; QUALITY OF LIFE; REMISSION; REVIEW; RISK FACTOR; RISK REDUCTION;

HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MEDICAL ERRORS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FITTING; TREATMENT OUTCOME;

EID: 79955953134     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-011-0172-7     Document Type: Review

References (50)

1. Rahimtoola SH. The problem of valve prosthesis-patient mismatch. Circulation. 1978;58:20-4. (Pubitemid 8376654)
2. Dumesnil JG, Honos GN, Lemieux M, Beauchemin J. Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography. J Am Coll Cardiol. 1990;16:637-43. (Pubitemid 20296128)
3. Dumesnil JG, Yoganathan AP. Valve prosthesis hemodynamics and the problem of high transprosthetic pressure gradients. Eur J Cardio-thorac Surg. 1992;6(Suppl I):S34-8.
4. Dumesnil JG, Honos GN, Lemieux M, Beauchemin J. Validation and applications of mitral prosthetic valvular areas calculated by Doppler echocardiography. Am J Cardiol. 1990;65:1443-8. (Pubitemid 20203260)
5. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol. 2000;36:1131-41.
6. Pibarot P, Dumesnil JG. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006;92:1022-9. (Pubitemid 44125207)
7. Koch CG, Khandwala F, Estafanous FG, Loop FD, Blackstone EH. Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation. 2005;111:3221-9. (Pubitemid 40874993)
8. Bleiziffer S, Eichinger WB, Hettich I, Guenzinger R, Ruzicka D, Bauernschmitt R, et al. Prediction of valve prosthesis-patient mismatch prior to aortic valve replacement: which is the best method? Heart 2007;93:615-20. This paper is very important from two standpoints: 1) it shows that the calculation of the projected indexed EOA from in vivo values is by far the best method to predict PPM; 2) it shows that the prevalence of PPM can significantly be reduced by the use of a preventive strategy based on the calculation of this parameter.
9. Monin JL. Prosthesis-patient mismatch: myth or reality? Heart. 2009;95:948-52.
10. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009;22:975-1014. These are the first comprehensive guidelines with regard to valve prosthesis evaluation by Doppler-echocardiography. Consensus recommendations with regard to assessment and impact of aortic and mitral PPM are presented. This article should be read in priority by all those concerned with this topic.
11. Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol. 2005;45:1034-40. (Pubitemid 40432435)
12. Magne J, Mathieu P, Dumesnil JG, Tanné D, Dagenais F, Doyle D, et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation 2007;115:1417-25. This is the first evidence of the negative impact of mitral PPM on survival.
13. Lam BK, Chan V, Hendry P, Ruel M, Masters R, Bédard P, et al. The impact of patient-prosthesis mismatch on late outcomes after mitral valve raplacement. J Thorac Cardiovasc Surg. 2007;133:1464-73.
14. Jamieson WR, Germann E, Ye J, Chan F, Cheung A, MacNab JS, et al. Effect of prosthesis-patient mismatch on long-term survival with mitral valve replacement: assessment to 15 years. Ann Thorac Surg. 2009;87:1135-41.
15. Aziz A, Lawton JS, Maniar HS, Pasque MK, Damiano Jr RJ, Moon MR. Factors affecting survival after mitral valve replacement in patients with prosthesis-patient mismatch. Ann Thorac Surg. 2010;90:1202-11.
16. Tasca G, Brunelli F, Cirillo M, Dalla Tomba M, Mhagna Z, Troise G, et al. Impact of the improvement of valve area achieved with aortic valve replacement on the regression of left ventricular hypertrophy in patients with pure aortic stenosis. Ann Thorac Surg. 2005;79:1291-6. (Pubitemid 40431853)
17. Dumesnil JG. Invited commentary. Ann Thorac Surg. 2005;79:1296.
18. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46:291-8. (Pubitemid 40966858)
19. Pagé A, Dumesnil JG, Clavel MA, Chan KL, Teo K, Tam JW, et al. Metabolic syndrome is associated with more pronounced impairment of LV geometry and function in patients with calcific aortic stenosis: A substudy of the ASTRONOMER trial. (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol 2010;55:1867-74. This paper presents new evidence showing that LVH is polymorphic and not only conditioned by valve hemodynamics
20. Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120:577-84. This paper presents new evidence showing that LVH is polymorphic and not only conditioned by valve hemodynamics.
21. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low flow, low gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115:2856-64. (Pubitemid 46869673)
22. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C, et al. B-type natriuretic peptide in low-flow, lowgradient aortic stenosis: relationship to hemodynamics and clinical outcome. Circulation. 2007;115:2848-55.
23. Dumesnil JG, Shoucri RM, Laurenceau JL, Turcot J. A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation. 1979;59:1024-34. (Pubitemid 9163962)
24. Pibarot P, Dumesnil JG. Longitudinal myocardial shortening in aortic stenosis: ready for prime time after 30 years of research? Heart. 2009;96:95-6.
25. Clavel MA, Fuchs C, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation. 2008;118(14 Suppl):S234-42.
26. Clavel MA, Webb J, Rodés-Cabau J, Masson JB, Dumont E, De Larochelliere R, et al. Comparison between surgical and transcatheter prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation. 2010;122:1943-51.
27. Clavel MA, Webb JG, Pibarot P, Altwegg L, Dumont E, Thompson C, et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 2009;5:1883-91. This study is one of the first to show that percutaneous aortic valve implantation provides superior hemodynamic performance compared with the surgical bioprostheses both in terms of transprosthetic gradient and prevention of severe PPM.
28. Jilaihawi H, Chin D, Spyt T, Jeilan M, Vasa-Nicotera M, Bence J, et al. Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis. Eur Heart J 2010;31:857-64. This study is one of the first to show that percutaneous aortic valve implantation provides superior hemodynamic performance compared with the surgical bioprostheses both in terms of transprosthetic gradient and prevention of severe PPM.
29. Rajappan K, Rimoldi O, Camici PG, Pennell DJ, Sheridan DJ. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation. 2002;105:470-6. (Pubitemid 34141704)
30. Rajappan K, Rimoldi OE, Camici PG, Bellenger NG, Pennell DJ, Sheridan DJ. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation. 2003;107:3170-5. (Pubitemid 36793087)
31. Garcia D, Camici PG, Durand LG, Rajappan K, Gaillard E, Rimoldi OE, et al. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol. 2009;106:113-21.
32. Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation. 2003;108:983-8. (Pubitemid 37048229)
33. Walther T, Rastan A, Falk V, Lehmann S, Garbade J, Funkat AK, et al. Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg. 2006;30:15-9. (Pubitemid 44183638)
34. Urso S, Sadaba R, Aldamiz-Echevarria G. Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement? Interact Cardiovasc Thorac Surg. 2009;9:510-8.
35. Ruel M, Al-Faleh H, Kulik A, Chan K, Mesana TG, Burwash IG. Prosthesis-patient mismatch after aortic valve replacement primarily affects patients with pre-existing left ventricular dysfunction: impact on survival, freedom from heart failure, and left ventricular mass regression. J Thorac Cardiovasc Surg. 2006;131:1036-44.
36. Bleiziffer S, Ali A, Hettich IM, Akdere D, Laubender RP, Ruzicka D, et al. Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement. Heart. 2010;96:865-71.
37. Mihaljevic T, Nowicki ER, Rajeswaran J, Blackstone EH, Lagazzi L, Thomas J, et al. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg. 2008;135:1270-8.
38. Mohty D, Dumesnil JG, Echahidi N, Mathieu P, Dagenais F, Voisine P, et al. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol 2009;53:39-47. Many discrepancies between studies examining the influence of PPM on long-term survival can be reconciled based on this paper.
39. Mascherbauer J, Rosenhek R, Fuchs C, Pernicka E, Klaar U, Scholten C, et al. Moderate patient-prosthesis mismatch after valve replacement for severe aortic stenosis has no impact on short- and long term mortality. Heart. 2008;94:1639-45.
40. Howell NJ, Keogh BE, Ray D, Bonser RS, Graham TR, Mascaro J, et al. Patient-prosthesis mismatch in patients with aortic stenosis undergoing isolated aortic valve replacement does not affect survival. Ann Thorac Surg. 2010;89:60-4.
41. Jamieson WR, Ye J, Higgins J, Cheung A, Fradet GJ, Skarsgard P, et al. Effect of prosthesis-patient mismatch on long-term survival with aortic valve replacement: assessment to 15 years. Ann Thorac Surg. 2010;89:51-8.
42. Moon MR, Lawton JS, Moazami N, Munfakh NA, Pasque MK, Damiano Jr RJ. POINT: Prosthesis-patient mismatch does not affect survival for patients greater than 70 years of age undergoing bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg. 2009;137:278-83.
43. Bleiziffer S, Eichinger WB, Hettich I, Ruzicka DJ, Wottke M, Bauernschmitt R, et al. Impact of prosthesis-patient mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement. Heart. 2008;94:637-41. (Pubitemid 351580141)
44. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343-9. (Pubitemid 36886240)
45. Mannacio VA, De Amicis V, Di Tommaso L, Iorio F, Vosa C. Influence of prosthesis-patient mismatch on exercise-induced arrhythmias: a further aspect after aortic valve replacement. J Thorac Cardiovasc Surg. 2009;138:632-8.
46. Unger P, Dedobbeleer C, Van Camp G, Plein D, Cosyns B, Lancellotti P. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart. 2009;96:1627-32.
47. Flameng W, Herregods MC, Vercalsteren M, Herijgers P, Bogaerts K, Meuris B. Prosthesis-patient mismatch predicts structural valve degeneration in bioprosthetic heart valves. Circulation. 2010;121:2123-9.
48. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034-48.
49. Bach DS. Echo/Doppler evaluation of hemodynamics after aortic valve replacement: Principles of interrogation and evaluation of high gradients. J Am Coll Cardio Img 2010;3:296-304. This paper interestingly complements previous attempts to analyze this problem (see Pibarot and Dumesnil [6], Zoghbi et al. [10], and Pibarot and Dumesnil [48]) and provides further impetus for the conception of Figure 1.
50. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve stenosis severity: a new index based on the energy loss concept. Circulation. 2000;101:765-71. (Pubitemid 30100083)